Figure 1.
Figure 1. Mean dose and median change in SF during deferasirox treatment in pediatric β-thalassemia patients

Mean dose and median change in SF during deferasirox treatment in pediatric β-thalassemia patients

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal